FPR as a prognostic biomarker in stage II and III gastric cancer

被引：0
|
作者：
Zhang, J. [1 ]
Wang, X-Z. [1 ]
Ying, H-Q. [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patients
    Jung, Peter
    Horst, David
    Kirchner, Thomas
    Klauschen, Frederick
    Neumann, Jens
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 235
  • [42] ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer
    Pu, Hongjiang
    Zhang, Shuai
    Yan, Shan
    Li, Chunxia
    Fu, Jiangping
    You, Dingyun
    Zhang, Tao
    Li, Zhenhui
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (01) : 179 - 189
  • [43] ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer
    Takaoka, Ayumi
    Ishikawa, Toshiaki
    Okazaki, Satoshi
    Watanabe, Shuichi
    Miya, Fuyuki
    Tsunoda, Tatsuhiko
    Kikuchi, Akifumi
    Yamauchi, Shinichi
    Matsuyama, Takatoshi
    Tokunaga, Masanori
    Uetake, Hiroyuki
    Kinugasa, Yusuke
    IN VIVO, 2021, 35 (01): : 191 - 201
  • [44] GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer
    Zhao, Zhixun
    Gao, Yibo
    Guan, Xu
    Liu, Zheng
    Jiang, Zheng
    Liu, Xiuyun
    Lin, Huixin
    Yang, Ming
    Li, Chunxiang
    Yang, Runkun
    Zou, Shuangmei
    Wang, Xishan
    GENES, 2018, 9 (07):
  • [45] Evaluating the Prognostic Significance of Lymphovascular Invasion in Stage II and III Colon Cancer
    Mutabdzic, D.
    O'Brien, S. B.
    Handorf, E.
    Devarajan, K.
    Reddy, S.
    Sigurdson, E. R.
    Denlinger, C.
    Meyer, J. E.
    Farma, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S110 - S110
  • [46] Prognostic relevance of Src activation in stage II-III colon cancer
    Martinez-Perez, Julia
    Lopez-Calderero, Iker
    Saez, Carmen
    Benavent, Marta
    Limon, Maria L.
    Gonzalez-Exposito, Reyes
    Soldevilla, Beatriz
    Carmen Riesco-Martinez, Maria
    Salamanca, Javier
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    HUMAN PATHOLOGY, 2017, 67 : 119 - 125
  • [47] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Yinchen Shen
    Xiaohong Han
    Jianfei Wang
    Shuai Wang
    Hongying Yang
    Shih-Hsin Lu
    Yuankai Shi
    Scientific Reports, 6
  • [48] Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer
    McLornan, Donal P.
    Barrett, Helen L.
    Cummins, Robert
    McDermott, Ultan
    McDowell, Cliona
    Conlon, Susie J.
    Coyle, Victoria M.
    Van Schaeybroeck, Sandra
    Wilson, Richard
    Kay, Elaine W.
    Longley, Daniel B.
    Johnston, Patrick G.
    CLINICAL CANCER RESEARCH, 2010, 16 (13) : 3442 - 3451
  • [49] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Shen, Yinchen
    Han, Xiaohong
    Wang, Jianfei
    Wang, Shuai
    Yang, Hongying
    Lu, Shih-Hsin
    Shi, Yuankai
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Sarcopenic obesity is a postoperative prognostic factor for stage II and III colorectal cancer
    Mizuno, Shodai
    Seishima, Ryo
    Okabayashi, Koji
    Shigeta, Kohei
    Matsui, Shimpei
    Kitagawa, Yuko
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (11) : 2951 - 2953
12345